神经心理障碍在肌缩侧面硬化-前光谱障碍中的神经心理障碍
1Human Cognitive Neuroscience, Department of Psychology, School of Philosophy, Psychology and Language Sciences, University of Edinburgh, Edinburgh, UK. s.abrahams@ed.ac.uk.
Nature reviews. Neurology
|October 12, 2023
概括
肌缩侧面硬化症 (ALS) 是一种影响运动神经元的神经退行性疾病. 神经心理学证据显示,ALS存在于一个频谱,包括认知和行为变化,影响患者护理和临床试验.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 心理学 心理学 心理学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,影响运动神经元.
- 前性痴呆症 (FTD) 与ALS具有重叠的病理特征.
- 将ALS重新构想为一种谱系障碍对于理解其完整的临床表现至关重要.
研究的目的:
- 审查支持ALS谱的神经心理学证据.
- 检查ALS和ALS-FTD的认知和行为变化.
- 突出神经心理学在ALS评估和研究中的作用.
主要方法:
- 对现有的ALS和FTD神经心理学研究的审查.
- 对整个ALS频谱的认知和行为缺陷的分析.
- 神经心理学发现与神经成像和病理学的相关性.
主要成果:
- 大约50%的ALS患者的认知能力正常,15%符合ALS-FTD标准,35%显示较轻微的损伤.
- 常见的缺陷包括语言流性,执行功能,社会认知和语言受损.
- 漠不关心是观察到的最常见的行为变化.
结论:
- 认知和行为变化是ALS表型的组成部分.
- 神经心理学评估工具对于研究和临床实践至关重要.
- 神经心理学作为ALS早期临床前变化的生物标志物.
相关概念视频
Alzheimer's Disease: Overview
503
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
503
Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
Alzheimer's Disease: Treatment
211
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
211
Dementia
121
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
121
Role of Cerebellum and Prefrontal Cortex in Memory
452
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
452
Autism Spectrum Disorder
117
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
117


